{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:10:11Z","timestamp":1788772211125,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1307602"],"award-info":[{"award-number":["2024YFA1307602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1307603"],"award-info":[{"award-number":["2024YFA1307603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1307601"],"award-info":[{"award-number":["2024YFA1307601"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jviromet.2026.115452","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:22:09Z","timestamp":1787847729000},"page":"115452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantification of HPV-16 and HPV-18 neutralizing antibodies via a magnetic bead-based competitive chemiluminescence platform"],"prefix":"10.1016","volume":"346","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6264-984X","authenticated-orcid":false,"given":"Linlin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiya","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-8026","authenticated-orcid":false,"given":"Ruo-Pan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2026.115452_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1086\/520654","article-title":"Quadrivalent human papillomavirus vaccine","volume":"45","author":"Barr","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2026.115452_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ijgo.12546","article-title":"Potential impact of introducing a nonavalent HPV vaccination","volume":"142","author":"Bogani","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.jviromet.2026.115452_bib3","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1016\/j.vaccine.2014.08.004","article-title":"Concordance assessment between a multiplexed competitive Luminex immunoassay, a multiplexed IgG Luminex immunoassay, and a pseudovirion-based neutralization assay for detection of human papillomavirus types 16 and 18","volume":"32","author":"Brown","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2026.115452_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay","volume":"115","author":"Deguchi","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2026.115452_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.4161\/hv.4.6.6912","article-title":"Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16\/18 cervical cancer vaccine","volume":"4","author":"Dessy","year":"2008","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.jviromet.2026.115452_bib6","first-page":"959","article-title":"Optimization and validation of a multiplexed Luminex assay to quantify antibodies to neutralizing epitopes on human papillomaviruses 6, 11, 16, and 18","volume":"12","author":"Dias","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jviromet.2026.115452_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cid\/ciw354","article-title":"Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience","volume":"63","author":"Garland","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2026.115452_bib8","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.str.2024.09.011","article-title":"Structural biology of the human papillomavirus","volume":"32","author":"Han","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.jviromet.2026.115452_bib9","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2026.115452_bib10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/vaccines9121413","article-title":"Human papillomavirus vaccine efficacy and effectiveness against cancer","volume":"9","author":"Kamolratanakul","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jviromet.2026.115452_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/infdis\/jiy516","article-title":"Bivalent human papillomavirus vaccine effectiveness in a Japanese population: high vaccine-type-specific effectiveness and evidence of cross-protection","volume":"219","author":"Kudo","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2026.115452_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jviromet.2026.115452_bib13","article-title":"Development of a 2-plex Luminex-based competitive immunoassay to quantify neutralizing antibodies induced by virus-like particles for human papillomavirus 16 and 18","volume":"2011","author":"Lv","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jviromet.2026.115452_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/ijgo.12075","article-title":"Overview of the benefits and potential issues of the nonavalent HPV vaccine","volume":"136","author":"Mariani","year":"2017","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.jviromet.2026.115452_bib15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4155\/bio.09.69","article-title":"Chemiluminescent enzyme immunoassays: a review of bioanalytical applications","volume":"1","author":"Marquette","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jviromet.2026.115452_bib16","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/jmv.23995","article-title":"Optimization and validation of a high throughput method for detecting neutralizing antibodies against human papillomavirus (HPV) based on pseudovirons","volume":"86","author":"Nie","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2026.115452_bib17","first-page":"108","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed Luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jviromet.2026.115452_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2026.115452_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2003.12.027","article-title":"Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18","volume":"321","author":"Pastrana","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2026.115452_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cmi.2015.05.001","article-title":"From the monovalent to the nine-valent HPV vaccine","volume":"21","author":"Pils","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jviromet.2026.115452_bib21","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S1470-2045(20)30524-6","article-title":"Efficacy of the bivalent HPV vaccine against HPV 16\/18-associated precancer: long-term follow-up results from the Costa Rica vaccine trial","volume":"21","author":"Porras","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jviromet.2026.115452_bib22","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jviromet.2026.115452_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074797","article-title":"Characteristics of HPV-specific antibody responses induced by infection and vaccination: cross-reactivity, neutralizing activity, avidity and IgG subclasses","volume":"8","author":"Scherpenisse","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.jviromet.2026.115452_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075677","article-title":"High-throughput pseudovirion-based neutralization assay for analysis of natural and vaccine-induced antibodies against human papillomaviruses","volume":"8","author":"Sehr","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.jviromet.2026.115452_bib25","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ygyno.2008.02.003","article-title":"Immunobiology of HPV and HPV vaccines","volume":"109","author":"Stanley","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jviromet.2026.115452_bib26","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.jviromet.2026.115452_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1872-2040(11)60518-5","article-title":"Chemiluminescent immunoassay and its applications","volume":"40","author":"Wang","year":"2012","journal-title":"Chin. J. Anal. Chem."},{"key":"10.1016\/j.jviromet.2026.115452_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"Wright","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jviromet.2026.115452_bib29","article-title":"Assessment of the ability of HPV vaccines to induce neutralizing antibodies based on pseudovirus-based neutralization assay","volume":"13","author":"Wu","year":"2025","journal-title":"Front. Public. Health"},{"key":"10.1016\/j.jviromet.2026.115452_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpha.2011.10.001","article-title":"Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum \u03b1-fetoprotein","volume":"2","author":"Zhang","year":"2012","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jviromet.2026.115452_bib31","first-page":"1","article-title":"Human papillomaviruses and their possible role in squamous cell carcinomas","volume":"78","author":"zur Hausen","year":"1977"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093426001175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093426001175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T08:39:51Z","timestamp":1788770391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093426001175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":31,"alternative-id":["S0166093426001175"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115452","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of HPV-16 and HPV-18 neutralizing antibodies via a magnetic bead-based competitive chemiluminescence platform","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2026.115452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115452"}}